A Search Service for Abbreviation / Long Form

â–  Abbreviation / Long Form : ROD / renal osteodystrophy

[Related PubMed/MEDLINE]
Total Number of Papers: 142
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   ROD  (>> Co-occurring Abbreviation)
Long Form:   renal osteodystrophy
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Fibroblast growth factor-23 may serve as a novel biomarker for renal osteodystrophy progression. FGF
2019 Serum bone markers in ROD patients across the spectrum of decreases in GFR: Activin A increases before all other markers
. CKD, FGF23, PTH
2018 Bone biopsy in nephrology practice. AP, CKD, PTH
2018 Bone Biopsy Results in Chronic Kidney Disease: a Single-Center Experience. AUC, BAP, CKD 5D, iPTH, MUO, OF, ROC
2018 Bone biopsy: an ally in the management of fragility fractures in chronic kidney disease. BMD, CKD, CKD- MBD, WHO
2018 Bone, inflammation and the bone marrow niche in chronic kidney disease: what do we know? BM, OP
2018 Determination of NF-kappaB and RANKL levels in peripheral blood osteoclast precursor cells in chronic kidney disease patients. CKD
2018 Expansive renal osteitis fibrosa: a case report. HPT
2018 Radiological manifestations of renal osteodystrophy in the orofacial region: a case report and literature review. ---
10  2018 Raman Spectroscopic and Microscopic Analysis for Monitoring Renal Osteodystrophy Signatures. ---
11  2018 Rethinking Bone Disease in Kidney Disease. CKD-MBD, ESKD
12  2018 Stenosis Before Thrombosis: Intracranial Hypertension from Jugular Foramen Stenosis Secondary to Renal Osteodystrophy. CVST, IIH
13  2018 Systemic Activation of Activin A Signaling Causes Chronic Kidney Disease-Mineral Bone Disorder. AL, CKD, CKD-MBD, PTH, RANKL, TGF
14  2018 [Treatment of Mandibular Fracture-Associated Infectious Pseudarthrosis Accompanied by Osteomyelitis in a Peritoneal Dialysis Patient]. CKD
15  2017 Bone biopsy practice patterns across Europe: the European renal osteodystrophy initiative-a position paper. CKD, EU-ROD, MBD
16  2017 Correction of lower limb deformities in children with renal osteodystrophy by guided growth technique. ---
17  2017 Is there a practical role for a virtual bone biopsy using high-resolution imaging of bone in patients with chronic kidney disease? CKD
18  2017 Positioning novel biologicals in CKD-mineral and bone disorders. CKD, CKD-MBD, OP, RANKL
19  2017 The importance of bone biopsy in chronic kidney disease-Mineral bone disorders. CKD, CKD-MBD, PTH
20  2017 Update on the role of bone biopsy in the management of patients with CKD-MBD. CKD, ESRD
21  2016 Bone Canopies in Pediatric Renal Osteodystrophy. CKD, PTH, RANKL
22  2016 Mineral and bone disorders, morbidity and mortality in end-stage renal failure patients on chronic dialysis. CDV, CKD-MBD, ESRF, HD, MBD, PD, VC
23  2016 Therapeutic effect of CNP on renal osteodystrophy by antagonizing the FGF-23/MAPK pathway. CKD, CNP, FGF
24  2016 Uremic Leontiasis Ossea in a Patient With Chronic Renal Insufficiency Demonstrated on Bone Scintigraphy. ---
25  2016 [The expanding concept of CKD-MBD]. CKD-MBD
26  2015 Bone Disorders in Chronic Kidney Disease: An Update in Diagnosis and Management. CKD, DXA
27  2015 Severe maxillofacial renal osteodystrophy in two patients with chronic kidney disease. CKD
28  2015 The importance of ultrasonographic measurement of peritoneal wall thickness in pediatric chronic peritoneal dialysis patients. BMI, BP, Hb, LVMI, PD, PET, PFS, US
29  2014 Development, validation and characterization of a novel mouse model of Adynamic Bone Disease (ABD). ABD, DXA, micro-CT, qBEI, TRAP
30  2014 Oral manifestations in a renal osteodystrophy patient - a case report with review of literature. CRD
31  2013 Advanced glycation end products suppress lysyl oxidase and induce bone collagen degradation in a rat model of renal osteodystrophy. AGEs, LOX, SPP1
32  2013 Bone disease in pediatric chronic kidney disease. CKD
33  2013 Brown tumor at the jaw in patients with secondary hyperparathyroidism due to chronic renal failure. ---
34  2013 High phosphate feeding promotes mineral and bone abnormalities in mice with chronic kidney disease. ALP, AMC, CKD, CKD-MBD, HP, NP
35  2013 Renale osteodystrophie. ---
36  2013 Severe renal osteodystrophy in a pediatric patient with end-stage renal disease: Sagliker syndrome? CKD, ESRD, PTH, SS
37  2012 The consequences of chronic kidney disease on bone metabolism and growth in children. CKD, CKD-MBD, GH
38  2012 [Kidney and bone update : the 5-year history and future of CKD-MBD. About the guideline of the Japanese Society for Dialysis Therapy]. CKD, CKD-MBD, JSDT
39  2011 Reproducibility and agreement of micro-CT and histomorphometry in human trabecular bone with different metabolic status. CV, micro-CT, OP
40  2011 Vascular calcifications and renal osteodystrophy in chronic hemodialysis patients: what is the relationship between them? Ca, CRP, HD, iPTH, VCs
41  2010 Four extremity fractures in a patient with renal osteodystrophy. ---
42  2010 Increased bone turnover markers after renal transplantation. CRF
43  2010 The importance of bone biomarkers in the diagnosis of renal osteodystrophy. ALP, CKD, HTO, iPTH, LTO
44  2010 [CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). Paradigm shift in CKD-MBD guideline]. CKD-MBD, JSDT
45  2009 Relationship between bone histology and markers of bone and mineral metabolism in African-American hemodialysis patients. AA, ABD, BSAP, HPT, iPTH, K/DOQI
46  2009 Role of bone biopsy in renal osteodystrophy. CKD
47  2009 Use of two calcium concentrations in hemodialysis--report of a 20-year clinical experience. CaD, HD, SHPT
48  2008 Bone histomorphometry in children prior to commencing renal replacement therapy. CKD, GFR, PTH, RRT, TMV, ULN
49  2008 Chronic kidney disease and bone fracture: a growing concern. aBMD, CKD, DXA, ESKD, PTH
50  2008 Correction of lower limb deformities in children with renal osteodystrophy by the Ilizarov method. ---
51  2007 Bone mineral density and bone histomorphometry in children on long-term dialysis. BMD, CKD, DXA, PTH
52  2007 Changes of serum bone markers in CAPD and hemodialysis patients. CAPD, DYP, HD, iPTH, OC, PIPC
53  2007 Correlation between parathyroid hormone, bone alkaline phosphatase and N-telopeptide of type 1 collagen in diabetic and non-diabetic haemodialysis patients. BAP, DN, HD, PTH
54  2007 Effect of haemodialysis on markers of bone turnover in children. BALP, C-PTH, ESRF
55  2007 Impact of etiology of chronic renal failure on growth in children. BSMMU, Ccr, CRF, iPTH
56  2007 Low-turnover bone disease in hypercalcemic hyperparathyroidism after kidney transplantation. FECa, iFGF23
57  2007 Outcomes of secondary hyperparathyroidism in chronic kidney disease and the direct costs of treatment. AWP, CKD, ESRD, LVH, PTH, SHPT
58  2007 Quantitative microcomputed tomography assessment of intratrabecular, intertrabecular, and cortical bone architecture in a rat model of severe renal osteodystrophy. BV/TV
59  2007 Renal osteodystrophy, phosphate homeostasis, and vascular calcification. CKD, PTH
60  2007 [Disorders of bone and mineral metabolism in CKD: CKD-MBD as a new entity]. CKD, GBMI, KDIGO, TMV
61  2007 [Guideline for the management of chronic kidney disease-related mineral and bone disorders (CKD-MBD)]. CKD, CKD-MBD, K/DOQI
62  2007 [Renal osteodystrophy]. CKD-MBD, K/DOQI
63  2006 Development of renal bone disease. CRF
64  2006 Diagnosis of renal osteodystrophy. DEXA, QCT
65  2006 Macrognathia secondary to dialysis-related renal osteodystrophy treated successfully by parathyroidectomy. ---
66  2006 Minimizing bone abnormalities in children with renal failure. CRF, PTH
67  2006 Prevalence and pattern of renal osteodystrophy in chronic hemodialysis patients: a cross sectional study of 103 patients. HD, iPTH
68  2006 Prevention and treatment of renal osteodystrophy in children on chronic renal failure: European guidelines. CRF, PTH
69  2006 Renal osteodystrophy: review of the disease and its treatment. CKD, PTH, RRT
70  2006 The influences of method of calcium correction and the timing of blood collection on application of the K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Japan. ---
71  2006 Uremic toxin and bone metabolism. ESRD, PTH
72  2006 [Renal osteodystrophy (ROD)]. ---
73  2005 Biochemical indices of renal osteodystrophy in dialysis patients on the island of Malta. bAP, iPTH
74  2005 Comparison of 1-84 and intact parathyroid hormone assay in pediatric dialysis patients. ESRD, iPTH, PTH
75  2005 Management of renal osteodystrophy in children. CRF, PTH
76  2005 Osteoprotegerin and bone mineral density in hemodiafiltration patients. BALP, BMD, CRF, HDF, OPG, PTH, QUS
77  2005 Renal osteodystrophy: a pediatric perspective, 2005. CKD
78  2005 Role of parathyroid hormone and therapy with active vitamin D sterols in renal osteodystrophy. CKD, PTH
79  2005 Specific measurement of PTH (1-84) in various forms of renal osteodystrophy (ROD) as assessed by bone histomorphometry. CKD, iPTH, PTH, ROC
80  2005 Using the ratio of serum osteoprotegerin ligand to osteoprotegerin to evaluate renal osteodystrophy in dialysis patients. ALP, HD, iP, PD
81  2005 [Serum beta-type I collagen carboxyterminal telopeptide (beta-CTXs) and bone involvement in chronic renal failure]. b-AL, Ccr, CRF, HD, iPTH, PD, PTH
82  2004 Association between fluoride, magnesium, aluminum and bone quality in renal osteodystrophy. PTH
83  2004 Bone biopsy as a diagnostic tool in the assessment of renal osteodystrophy. ESRF
84  2004 Bone biopsy in the diagnosis of renal osteodystrophy. ---
85  2004 Quantitative high-resolution magnetic resonance imaging reveals structural implications of renal osteodystrophy on trabecular and cortical bone. BMI, CCA, EI, FLASE, MCT, micro-MRI, RCA, SURF and CURV
86  2004 Renal osteodystrophy in pediatric patients on peritoneal dialysis. iPTH, nPNA, PD
87  2004 Renal osteodystrophy. PTH
88  2004 The evaluation of renal osteodystrophy with cortical quantitative ultrasound at various bone sites. CRF, QUS, SOS
89  2004 The importance of bone health in end-stage renal disease: out of the frying pan, into the fire? CKD
90  2003 A multicenter study on the effects of lanthanum carbonate (Fosrenol) and calcium carbonate on renal bone disease in dialysis patients. CC, LC
91  2003 Bone biopsy: indications, techniques, and complications. ESRD
92  2003 Correlation between histomorphometric parameters of bone resorption and serum type 5b tartrate-resistant acid phosphatase in uremic patients on maintenance hemodialysis. HPT, iPTH
93  2003 Evaluation of parathyroid hyperplasia by ultrasonographic examination in patients with end-stage renal failure before and at initiation of dialysis. CRF, ESRF, PTH
94  2003 Sevelamer hydrochloride prevents ectopic calcification and renal osteodystrophy in chronic renal failure rats. PTH
95  2003 Spectrum of renal bone disease in end-stage renal failure patients not yet on dialysis. ABD, ESRF, HPTH, MX, OM
96  2003 The renal osteodystrophy pattern in Brazil and Uruguay: an overview. CAPD, HD, HP
97  2003 Useful biochemical markers for diagnosing renal osteodystrophy in predialysis end-stage renal failure patients. ABD, BAP, ESRF, OC, OM, PPV
98  2003 [Recent medication to renal osteodystrophy]. ---
99  2003 [Renal osteodystrophy and vitamin D]. ---
100  2003 [Renal osteodystrophy Guidelines]. BTD, iPTH